IBDEI070 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9167,0)
 ;;=374.20^^63^610^72
 ;;^UTILITY(U,$J,358.3,9167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9167,1,3,0)
 ;;=3^Lagophthalmos
 ;;^UTILITY(U,$J,358.3,9167,1,4,0)
 ;;=4^374.20
 ;;^UTILITY(U,$J,358.3,9167,2)
 ;;=Lagophthalmos^265452
 ;;^UTILITY(U,$J,358.3,9168,0)
 ;;=378.9^^63^610^98
 ;;^UTILITY(U,$J,358.3,9168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9168,1,3,0)
 ;;=3^Strabismus
 ;;^UTILITY(U,$J,358.3,9168,1,4,0)
 ;;=4^378.9
 ;;^UTILITY(U,$J,358.3,9168,2)
 ;;=Strabismus^123833
 ;;^UTILITY(U,$J,358.3,9169,0)
 ;;=242.90^^63^610^99
 ;;^UTILITY(U,$J,358.3,9169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9169,1,3,0)
 ;;=3^Thyrotoxicosis w/o Crisis Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,9169,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,9169,2)
 ;;=Thyroid Eye Disease^267811^376.21
 ;;^UTILITY(U,$J,358.3,9170,0)
 ;;=374.05^^63^610^100
 ;;^UTILITY(U,$J,358.3,9170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9170,1,3,0)
 ;;=3^Trichiasis w/o Entropion
 ;;^UTILITY(U,$J,358.3,9170,1,4,0)
 ;;=4^374.05
 ;;^UTILITY(U,$J,358.3,9170,2)
 ;;=Trichiasis^269082
 ;;^UTILITY(U,$J,358.3,9171,0)
 ;;=375.21^^63^610^69
 ;;^UTILITY(U,$J,358.3,9171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9171,1,3,0)
 ;;=3^Lacrimal,Epiphora,Excess
 ;;^UTILITY(U,$J,358.3,9171,1,4,0)
 ;;=4^375.21
 ;;^UTILITY(U,$J,358.3,9171,2)
 ;;=Epiphora, excess lacrimation^269137
 ;;^UTILITY(U,$J,358.3,9172,0)
 ;;=375.22^^63^610^23
 ;;^UTILITY(U,$J,358.3,9172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9172,1,3,0)
 ;;=3^Epiphora, Insuff Drainage
 ;;^UTILITY(U,$J,358.3,9172,1,4,0)
 ;;=4^375.22
 ;;^UTILITY(U,$J,358.3,9172,2)
 ;;=Epiphora, Insuff Drainage^269138
 ;;^UTILITY(U,$J,358.3,9173,0)
 ;;=375.53^^63^610^67
 ;;^UTILITY(U,$J,358.3,9173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9173,1,3,0)
 ;;=3^Lacrimal,Canal Stenosis
 ;;^UTILITY(U,$J,358.3,9173,1,4,0)
 ;;=4^375.53
 ;;^UTILITY(U,$J,358.3,9173,2)
 ;;=Lacrimal Canal Stenosis^269154
 ;;^UTILITY(U,$J,358.3,9174,0)
 ;;=375.51^^63^610^70
 ;;^UTILITY(U,$J,358.3,9174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9174,1,3,0)
 ;;=3^Lacrimal,Punctum Eversion
 ;;^UTILITY(U,$J,358.3,9174,1,4,0)
 ;;=4^375.51
 ;;^UTILITY(U,$J,358.3,9174,2)
 ;;=Lacrimal Punctum Eversion^269150
 ;;^UTILITY(U,$J,358.3,9175,0)
 ;;=375.54^^63^610^71
 ;;^UTILITY(U,$J,358.3,9175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9175,1,3,0)
 ;;=3^Lacrimal,Sac Stenosis
 ;;^UTILITY(U,$J,358.3,9175,1,4,0)
 ;;=4^375.54
 ;;^UTILITY(U,$J,358.3,9175,2)
 ;;=Lacrimal Punctum Stenosis^269156
 ;;^UTILITY(U,$J,358.3,9176,0)
 ;;=375.56^^63^610^78
 ;;^UTILITY(U,$J,358.3,9176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9176,1,3,0)
 ;;=3^Nasolacrimal Duct Obstruction
 ;;^UTILITY(U,$J,358.3,9176,1,4,0)
 ;;=4^375.56
 ;;^UTILITY(U,$J,358.3,9176,2)
 ;;=Obstruction, Nasolacrimal duct^269159
 ;;^UTILITY(U,$J,358.3,9177,0)
 ;;=376.30^^63^610^87
 ;;^UTILITY(U,$J,358.3,9177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9177,1,3,0)
 ;;=3^Orbit Exophalmos
 ;;^UTILITY(U,$J,358.3,9177,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,9177,2)
 ;;=Exophthalmos^43683
 ;;^UTILITY(U,$J,358.3,9178,0)
 ;;=802.8^^63^610^88
 ;;^UTILITY(U,$J,358.3,9178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9178,1,3,0)
 ;;=3^Orbit Fracture
 ;;^UTILITY(U,$J,358.3,9178,1,4,0)
 ;;=4^802.8
 ;;^UTILITY(U,$J,358.3,9178,2)
 ;;=Fracture of Orbit^25315
 ;;^UTILITY(U,$J,358.3,9179,0)
 ;;=870.4^^63^610^92
 ;;^UTILITY(U,$J,358.3,9179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9179,1,3,0)
 ;;=3^Orbit Penetrating Wound w/ Foreign Body
 ;;^UTILITY(U,$J,358.3,9179,1,4,0)
 ;;=4^870.4
 ;;^UTILITY(U,$J,358.3,9179,2)
 ;;=Foreign Body in Orbit^274883
 ;;^UTILITY(U,$J,358.3,9180,0)
 ;;=376.10^^63^610^91
 ;;^UTILITY(U,$J,358.3,9180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9180,1,3,0)
 ;;=3^Orbit Inflammation,Chronic
 ;;^UTILITY(U,$J,358.3,9180,1,4,0)
 ;;=4^376.10
 ;;^UTILITY(U,$J,358.3,9180,2)
 ;;=Orbital Inflammation^269175
 ;;^UTILITY(U,$J,358.3,9181,0)
 ;;=360.41^^63^610^66
 ;;^UTILITY(U,$J,358.3,9181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9181,1,3,0)
 ;;=3^Hypotensive Blind Phthisis,Blind
 ;;^UTILITY(U,$J,358.3,9181,1,4,0)
 ;;=4^360.41
 ;;^UTILITY(U,$J,358.3,9181,2)
 ;;=Phthisis^268564
 ;;^UTILITY(U,$J,358.3,9182,0)
 ;;=376.50^^63^610^86
 ;;^UTILITY(U,$J,358.3,9182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9182,1,3,0)
 ;;=3^Orbit Enopthalmos
 ;;^UTILITY(U,$J,358.3,9182,1,4,0)
 ;;=4^376.50
 ;;^UTILITY(U,$J,358.3,9182,2)
 ;;=Enopthalmos^40801
 ;;^UTILITY(U,$J,358.3,9183,0)
 ;;=239.2^^63^610^95
 ;;^UTILITY(U,$J,358.3,9183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9183,1,3,0)
 ;;=3^Orbital Tumor,Neopl,Unspec Nature
 ;;^UTILITY(U,$J,358.3,9183,1,4,0)
 ;;=4^239.2
 ;;^UTILITY(U,$J,358.3,9183,2)
 ;;=Orbital Tumor^267783
 ;;^UTILITY(U,$J,358.3,9184,0)
 ;;=239.7^^63^610^79
 ;;^UTILITY(U,$J,358.3,9184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9184,1,3,0)
 ;;=3^Optic Nerve Neop,Unspec Nature
 ;;^UTILITY(U,$J,358.3,9184,1,4,0)
 ;;=4^239.7
 ;;^UTILITY(U,$J,358.3,9184,2)
 ;;=Optic Nerve Tumor^267785
 ;;^UTILITY(U,$J,358.3,9185,0)
 ;;=V52.2^^63^610^2
 ;;^UTILITY(U,$J,358.3,9185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9185,1,3,0)
 ;;=3^Artificial Eye Prosthethic Check
 ;;^UTILITY(U,$J,358.3,9185,1,4,0)
 ;;=4^V52.2
 ;;^UTILITY(U,$J,358.3,9185,2)
 ;;=Prosthethic Eye Check^295498^V43.0
 ;;^UTILITY(U,$J,358.3,9186,0)
 ;;=173.10^^63^610^56
 ;;^UTILITY(U,$J,358.3,9186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9186,1,3,0)
 ;;=3^Eyelid/Canthus,Malig Neopl,Unspec
 ;;^UTILITY(U,$J,358.3,9186,1,4,0)
 ;;=4^173.10
 ;;^UTILITY(U,$J,358.3,9186,2)
 ;;=^340597
 ;;^UTILITY(U,$J,358.3,9187,0)
 ;;=173.11^^63^610^53
 ;;^UTILITY(U,$J,358.3,9187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9187,1,3,0)
 ;;=3^Eyelid/Canthus,BCC
 ;;^UTILITY(U,$J,358.3,9187,1,4,0)
 ;;=4^173.11
 ;;^UTILITY(U,$J,358.3,9187,2)
 ;;=^340467
 ;;^UTILITY(U,$J,358.3,9188,0)
 ;;=173.12^^63^610^57
 ;;^UTILITY(U,$J,358.3,9188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9188,1,3,0)
 ;;=3^Eyelid/Canthus,SCC
 ;;^UTILITY(U,$J,358.3,9188,1,4,0)
 ;;=4^173.12
 ;;^UTILITY(U,$J,358.3,9188,2)
 ;;=^340468
 ;;^UTILITY(U,$J,358.3,9189,0)
 ;;=173.19^^63^610^55
 ;;^UTILITY(U,$J,358.3,9189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9189,1,3,0)
 ;;=3^Eyelid/Canthus,Malig Neopl,Oth
 ;;^UTILITY(U,$J,358.3,9189,1,4,0)
 ;;=4^173.19
 ;;^UTILITY(U,$J,358.3,9189,2)
 ;;=^340469
 ;;^UTILITY(U,$J,358.3,9190,0)
 ;;=053.20^^63^610^51
 ;;^UTILITY(U,$J,358.3,9190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9190,1,3,0)
 ;;=3^Eyelid,Herpes Zoster
 ;;^UTILITY(U,$J,358.3,9190,1,4,0)
 ;;=4^053.20
 ;;^UTILITY(U,$J,358.3,9190,2)
 ;;=^56937
 ;;^UTILITY(U,$J,358.3,9191,0)
 ;;=054.41^^63^610^50
 ;;^UTILITY(U,$J,358.3,9191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9191,1,3,0)
 ;;=3^Eyelid,Herpes Simplex
 ;;^UTILITY(U,$J,358.3,9191,1,4,0)
 ;;=4^054.41
 ;;^UTILITY(U,$J,358.3,9191,2)
 ;;=^266563
 ;;^UTILITY(U,$J,358.3,9192,0)
 ;;=078.0^^63^610^77
 ;;^UTILITY(U,$J,358.3,9192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9192,1,3,0)
 ;;=3^Molluscum Contagiosum
 ;;^UTILITY(U,$J,358.3,9192,1,4,0)
 ;;=4^078.0
 ;;^UTILITY(U,$J,358.3,9192,2)
 ;;=^78675
 ;;^UTILITY(U,$J,358.3,9193,0)
 ;;=228.1^^63^610^76
 ;;^UTILITY(U,$J,358.3,9193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9193,1,3,0)
 ;;=3^Lymphangioma
 ;;^UTILITY(U,$J,358.3,9193,1,4,0)
 ;;=4^228.1
 ;;^UTILITY(U,$J,358.3,9193,2)
 ;;=^72391
 ;;^UTILITY(U,$J,358.3,9194,0)
 ;;=238.2^^63^610^3
 ;;^UTILITY(U,$J,358.3,9194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9194,1,3,0)
 ;;=3^Benign Neopl,Oth & Unspec Sites/Tissue
 ;;^UTILITY(U,$J,358.3,9194,1,4,0)
 ;;=4^238.2
 ;;^UTILITY(U,$J,358.3,9194,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,9195,0)
 ;;=242.00^^63^610^61
 ;;^UTILITY(U,$J,358.3,9195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9195,1,3,0)
 ;;=3^Goiter Toxic Dif/Graves Thyrotoxic Exoph
 ;;^UTILITY(U,$J,358.3,9195,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,9195,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,9196,0)
 ;;=272.2^^63^610^101
 ;;^UTILITY(U,$J,358.3,9196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9196,1,3,0)
 ;;=3^Xanthelasma
 ;;^UTILITY(U,$J,358.3,9196,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,9196,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,9197,0)
 ;;=360.40^^63^610^60
 ;;^UTILITY(U,$J,358.3,9197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9197,1,3,0)
 ;;=3^Globe/Eye Degenerative,Unspec
 ;;^UTILITY(U,$J,358.3,9197,1,4,0)
 ;;=4^360.40
 ;;^UTILITY(U,$J,358.3,9197,2)
 ;;=^268563
 ;;^UTILITY(U,$J,358.3,9198,0)
 ;;=360.42^^63^610^65
 ;;^UTILITY(U,$J,358.3,9198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9198,1,3,0)
 ;;=3^Hypertensive Blind/Absolute Glaucoma
 ;;^UTILITY(U,$J,358.3,9198,1,4,0)
 ;;=4^360.42
 ;;^UTILITY(U,$J,358.3,9198,2)
 ;;=^268565
 ;;^UTILITY(U,$J,358.3,9199,0)
 ;;=360.89^^63^610^59
 ;;^UTILITY(U,$J,358.3,9199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9199,1,3,0)
 ;;=3^Globe D/O,Other
 ;;^UTILITY(U,$J,358.3,9199,1,4,0)
 ;;=4^360.89
 ;;^UTILITY(U,$J,358.3,9199,2)
 ;;=^268581
 ;;^UTILITY(U,$J,358.3,9200,0)
 ;;=373.01^^63^610^5
 ;;^UTILITY(U,$J,358.3,9200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9200,1,3,0)
 ;;=3^Blepharitis,Ulcerative
 ;;^UTILITY(U,$J,358.3,9200,1,4,0)
 ;;=4^373.01
 ;;^UTILITY(U,$J,358.3,9200,2)
 ;;=^269053
 ;;^UTILITY(U,$J,358.3,9201,0)
 ;;=373.31^^63^610^49
 ;;^UTILITY(U,$J,358.3,9201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9201,1,3,0)
 ;;=3^Eyelid,Dermatitis,Eczematous
 ;;^UTILITY(U,$J,358.3,9201,1,4,0)
 ;;=4^373.31
 ;;^UTILITY(U,$J,358.3,9201,2)
 ;;=^269060
 ;;^UTILITY(U,$J,358.3,9202,0)
 ;;=373.34^^63^610^52
 ;;^UTILITY(U,$J,358.3,9202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9202,1,3,0)
 ;;=3^Eyelid,Lupus Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,9202,1,4,0)
 ;;=4^373.34
 ;;^UTILITY(U,$J,358.3,9202,2)
 ;;=^269064
 ;;^UTILITY(U,$J,358.3,9203,0)
 ;;=373.9^^63^610^37
